Skip to main content

Table 1 Distribution of ER and HER2 status

From: New network topology approaches reveal differential correlation patterns in breast cancer

Microarray cohort Californian population[36]
Total 1317 (100%) 100%
ER+ 1035 (78.6%) 79.4%
ER- 282 (21.4%) 20.6%
HER2+ 208 (15.8%) 21.7%
HER2- 1109 (84.2%) 78.3%
ER+/HER2+ 120 (9.1%) 14.6%
ER+/HER2- 915 (69.5%) 64.8%
ER-/HER2+ 88 (6.7%) 7.1%
ER-/HER2- 194 (14.7%) 13.5%
  1. Distribution of ER and HER2 status in the microarray cohort and in a large Californian population of 67698 breast cancer patients.